CEN Biotech, Inc.
CENBF
$0.0001
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -20.64% | -34.53% | 87.48% | -187.73% | 95.36% |
| Total Depreciation and Amortization | 697.22% | -73.16% | -12.89% | -23.82% | 33.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | 222.73% | -88.39% |
| Total Other Non-Cash Items | 2,820.00% | -- | -100.00% | 360.57% | -97.36% |
| Change in Net Operating Assets | 62.67% | -142.06% | 98.52% | -72.98% | -26.74% |
| Cash from Operations | 75.19% | -526.03% | 27.04% | -471.50% | 109.89% |
| Capital Expenditure | -- | -- | -- | 77.89% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | 470.71% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 2.23% | -- |
| Cash from Investing | -- | -- | -- | -130.42% | 366.71% |
| Total Debt Issued | 18.29% | -- | -- | 2,400.00% | -98.73% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.06% | -- | -- | 2,400.00% | -98.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 159.38% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -188.34% | 295.17% | -181.55% | -110.15% | 1,909.90% |
